The funding will enable Sovato to scale its first-of-its-kind platform, empowering healthcare organizations to safely extend surgical expertise anywhere.
Sovato, a company enabling healthcare organizations to implement and scale remote robotic surgery and procedure programs announced the close of its Series B, bringing total funding to $41 million.
Health Technology Insights: SimiTree Launches CLARITY for Real-Time Revenue Insights
“Remote robotic surgery and procedure programs provide healthcare organizations with a practical way to extend the reach and impact of skilled surgeons, care teams, and operating rooms—enabling a more sustainable and accessible model of care.”
Growth-stage venture capital firm Beringea led the round, with significant follow-on investments from existing investors. Notable participants include founding investor Polaris Partners, Intuitive, GS Ventures, Laerdal Million Lives Fund, Puma Venture Capital, Teladoc Health, and other private investors. The funding will accelerate development of Sovato’s platform and advance strategic partnerships with surgical robotics companies, healthcare providers, and ecosystem collaborators.
Health Technology Insights: Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M
With the global robotic surgery market projected to grow 12.4% annually through 2030 and more than 246 companies in the market healthcare providers face more choices than ever as systems become increasingly specialized. Sovato’s system-agnostic platform can remote-enable any surgical, interventional, or diagnostic robotic system, allowing physicians to perform these procedures remotely. This technology positions Sovato at the forefront of a major transformation in healthcare delivery.
“Over half the world’s population lacks access to timely, safe surgical care, and in the U.S., millions are still forced to travel for routine procedures—a challenge that will only grow as surgeon shortages intensify,” said Cynthia Perazzo, Co-Founder and CEO of Sovato. “Remote robotic surgery and procedure programs provide healthcare organizations with a practical way to extend the reach and impact of skilled surgeons, care teams, and operating rooms—enabling a more sustainable and accessible model of care.”
Collaborating with Industry-leading Partners
Sovato has successfully integrated with leading robotic systems and has demonstrated the safety and feasibility in preclinical cases conducted over distances ranging from hundreds to thousands of miles, both in the U.S. and internationally. These cases highlight the ability to extend expert surgical care across vast distances, emulating a real-world hub-and-spoke model.
“With this Series B funding and three years of proven momentum, Sovato is well-positioned to scale the only platform creating the market for remote surgery and procedure programs,” said Michael Gross, Beringea Managing Partner and Sovato board director. “Co-Founders Dr. Yulun Wang, whose innovations have shaped the surgical robotics industry, and Cynthia Perazzo, along with the entire Sovato team, bring the leadership and bold vision to redefine surgical access and healthcare economics.”
Sovato is collaborating with healthcare leaders and robotics organizations to establish clinical, operational, and technical guidelines for remote robotic surgery and procedures—laying the foundation for safe, effective, and scalable adoption worldwide.
Health Technology Insights: FDA Approves Interchangeable Status for Fresenius Kabi Biosimilars
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
